ArticleBMJ open2024

Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial.

Nikolaj Torp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.